KYMR
Price
$29.64
Change
-$0.61 (-2.02%)
Updated
May 30 closing price
Capitalization
1.93B
60 days until earnings call
NRIX
Price
$11.71
Change
+$1.08 (+10.16%)
Updated
Jun 2, 10:32 AM (EDT)
Capitalization
810.38M
38 days until earnings call
Interact to see
Advertisement

KYMR vs NRIX

Header iconKYMR vs NRIX Comparison
Open Charts KYMR vs NRIXBanner chart's image
Kymera Therapeutics
Price$29.64
Change-$0.61 (-2.02%)
Volume$651.49K
Capitalization1.93B
Nurix Therapeutics
Price$11.71
Change+$1.08 (+10.16%)
Volume$10.59K
Capitalization810.38M
KYMR vs NRIX Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. NRIX commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and NRIX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (KYMR: $29.64 vs. NRIX: $10.63)
Brand notoriety: KYMR and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 90% vs. NRIX: 94%
Market capitalization -- KYMR: $1.93B vs. NRIX: $810.38M
KYMR [@Biotechnology] is valued at $1.93B. NRIX’s [@Biotechnology] market capitalization is $810.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than NRIX.

Price Growth

KYMR (@Biotechnology) experienced а +0.51% price change this week, while NRIX (@Biotechnology) price change was +9.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

NRIX is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.93B) has a higher market cap than NRIX($810M). KYMR YTD gains are higher at: -26.324 vs. NRIX (-43.577). NRIX has higher annual earnings (EBITDA): -214M vs. KYMR (-232.67M). NRIX has more cash in the bank: 550M vs. KYMR (463M). NRIX has less debt than KYMR: NRIX (26.6M) vs KYMR (86.3M). KYMR (58.9M) and NRIX (56.4M) have equivalent revenues.
KYMRNRIXKYMR / NRIX
Capitalization1.93B810M238%
EBITDA-232.67M-214M109%
Gain YTD-26.324-43.57760%
P/E RatioN/AN/A-
Revenue58.9M56.4M104%
Total Cash463M550M84%
Total Debt86.3M26.6M324%
TECHNICAL ANALYSIS
Technical Analysis
KYMRNRIX
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCBAX15.000.03
+0.20%
BlackRock Tactical Opportunities Inv A
FNEEX62.99-0.05
-0.08%
American Funds New Economy 529-F-2
IYSMX15.88-0.06
-0.38%
Macquarie Smid Cap Core Fund Class R
SMDRX18.85-0.08
-0.42%
Hartford Schroders US MidCap Opps SDR
RYOIX61.53-0.79
-1.27%
Rydex Biotechnology Inv

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.02%
CCCC - KYMR
63%
Loosely correlated
-5.30%
NRIX - KYMR
59%
Loosely correlated
-0.09%
RVMD - KYMR
57%
Loosely correlated
+0.81%
CGON - KYMR
56%
Loosely correlated
-2.33%
IMNM - KYMR
56%
Loosely correlated
-2.12%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-0.09%
KYMR - NRIX
59%
Loosely correlated
-2.02%
DNLI - NRIX
56%
Loosely correlated
-2.22%
IDYA - NRIX
53%
Loosely correlated
-0.80%
BEAM - NRIX
50%
Loosely correlated
-3.00%
STOK - NRIX
49%
Loosely correlated
-1.95%
More